Core Insights - On September 2, Weining Health experienced a 3.60% decline in stock price with a trading volume of 775 million yuan [1] - The company reported a financing buy-in of 124 million yuan and a net financing buy of 25.736 million yuan on the same day [1] - As of September 2, the total financing and securities lending balance for Weining Health was 1.406 billion yuan, indicating a high level of financing activity [1] Financing and Securities Lending - On September 2, Weining Health had a financing buy-in of 124 million yuan, with a financing balance of 1.402 billion yuan, accounting for 6.57% of its market capitalization [1] - The financing balance is above the 90th percentile of the past year, indicating a high level of investor interest [1] - In terms of securities lending, 2,100 shares were repaid, and 21,000 shares were sold, with a total selling amount of 202,400 yuan [1] - The remaining securities lending volume was 396,500 shares, with a balance of 3.8224 million yuan, also above the 50th percentile of the past year [1] Company Overview - Weining Health Technology Group Co., Ltd. was established on April 7, 2004, and listed on August 18, 2011 [1] - The company specializes in the research, development, sales, and technical services of medical software, providing comprehensive solutions for the healthcare industry's information technology [1] - The revenue composition of Weining Health includes 84.65% from software and services, 7.89% from hardware sales, and 7.46% from internet healthcare [1] Shareholder Information - As of August 20, Weining Health had 119,900 shareholders, a decrease of 2.70% from the previous period [2] - The average number of circulating shares per shareholder increased by 2.78% to 15,956 shares [2] - For the first half of 2025, Weining Health reported a revenue of 839 million yuan, a year-on-year decrease of 31.43%, and a net profit attributable to shareholders of -118 million yuan, a decrease of 491.04% [2] Dividend and Institutional Holdings - Weining Health has distributed a total of 455 million yuan in dividends since its A-share listing, with 97.226 million yuan distributed over the past three years [2] - As of June 30, 2025, the top ten circulating shareholders included Huabao Zhongzheng Medical ETF and E-Fund Growth Enterprise Board ETF, with notable changes in their holdings [2]
卫宁健康9月2日获融资买入1.24亿元,融资余额14.02亿元